The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality
Intensive Care Medicine, 02/15/2011
The study run–in phase has been completed and the main trial commenced in April 2010. Crystalloid versus Hydroxyethyl Starch Trial (CHEST) should generate results that will inform and influence prescribing of this commonly used resuscitation fluid.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.